Hyster-Yale (HY) Financials

Hyster-Yale logo
$26.23 -0.39 (-1.46%)
Closing price 03:59 PM Eastern
Extended Trading
$26.25 +0.02 (+0.07%)
As of 04:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Hyster-Yale

Annual Income Statements for Hyster-Yale

This table shows Hyster-Yale's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
75 43 49 35 36 37 -173 -74 126 142 -60
Consolidated Net Income / (Loss)
75 42 49 34 37 39 -183 -72 128 144 -58
Net Income / (Loss) Continuing Operations
75 42 49 34 37 39 -183 -72 128 131 -100
Total Pre-Tax Income
105 38 94 37 48 42 -155 -62 181 219 -43
Total Operating Income
104 33 74 39 54 50 -152 -39 209 245 -22
Total Gross Profit
431 428 503 497 542 465 363 434 786 896 633
Total Revenue
2,578 2,570 2,885 3,179 3,292 2,812 3,076 3,548 4,118 4,308 3,769
Operating Revenue
2,578 2,570 2,885 3,179 3,292 2,812 3,076 3,548 4,118 4,308 3,769
Total Cost of Revenue
2,147 2,142 2,383 2,682 2,750 2,347 2,712 3,114 3,333 3,413 3,137
Operating Cost of Revenue
2,147 2,142 2,383 2,682 2,750 2,347 2,712 3,114 3,333 3,413 3,137
Total Operating Expenses
327 395 429 458 488 416 516 473 577 664 696
Selling, General & Admin Expense
327 395 429 458 488 416 450 473 577 628 617
Impairment Charge
- - - - - 0.00 66 0.00 0.00 0.00 6.80
Restructuring Charge
- - - - - - - 0.00 0.00 36 73
Total Other Income / (Expense), net
1.00 5.40 20 -2.20 -6.00 -7.70 -2.60 -23 -28 -26 -21
Interest Expense
4.70 6.70 15 16 20 14 16 28 37 34 31
Interest & Investment Income
6.10 7.10 28 10 9.30 6.60 12 11 9.80 5.50 10
Other Income / (Expense), net
-0.40 5.00 6.30 3.80 4.50 -0.60 1.20 -5.90 -0.20 2.50 0.00
Income Tax Expense
29 -4.00 45 2.30 11 3.70 28 9.20 53 75 15
Net Income / (Loss) Attributable to Noncontrolling Interest
0.40 -0.50 0.30 -0.40 0.80 1.40 -10 2.50 2.20 1.90 2.10
Basic Earnings per Share
$4.58 $2.61 $2.95 $2.10 $2.15 $2.21 ($10.29) ($4.38) $7.35 $8.16 ($3.40)
Weighted Average Basic Shares Outstanding
16.31M 16.38M 16.45M 16.54M 16.67M 16.81M 16.84M 17.16M 17.49M 17.70M 17.90M
Diluted Earnings per Share
$4.57 $2.61 $2.94 $2.09 $2.14 $2.21 ($10.29) ($4.38) $7.24 $8.04 ($3.40)
Weighted Average Diluted Shares Outstanding
16.31M 16.38M 16.45M 16.54M 16.67M 16.81M 16.84M 17.16M 17.49M 17.70M 17.90M
Weighted Average Basic & Diluted Shares Outstanding
16.31M 16.38M 16.45M 16.54M 16.67M 16.81M 16.84M 17.16M 17.49M 17.70M 17.90M
Cash Dividends to Common per Share
$1.13 $1.17 $1.20 $1.23 $1.26 $1.27 $1.29 $1.29 $1.30 $1.38 $1.43

Quarterly Income Statements for Hyster-Yale

This table shows Hyster-Yale's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
52 63 17 10 8.60 -14 -2.30 -53 -31 -32 -15
Consolidated Net Income / (Loss)
52 64 18 11 8.70 -13 -1.70 -52 -30 -31 -14
Net Income / (Loss) Continuing Operations
52 64 18 27 8.70 -13 -1.70 -93 -41 -31 -14
Total Pre-Tax Income
77 90 28 24 17 -13 -4.60 -42 -32 -23 -14
Total Operating Income
84 96 33 32 21 -8.50 2.30 -37 -28 -18 -9.10
Total Gross Profit
236 259 193 208 178 168 156 131 125 128 124
Total Revenue
1,057 1,168 1,016 1,068 910 957 979 923 795 813 827
Operating Revenue
1,057 1,168 1,016 1,068 910 957 979 923 795 813 827
Total Cost of Revenue
821 909 823 860 733 788 823 792 670 685 703
Operating Cost of Revenue
821 909 823 860 733 788 823 792 670 685 703
Total Operating Expenses
152 164 160 160 157 177 154 209 164 146 133
Selling, General & Admin Expense
152 164 159 153 156 161 153 147 151 144 132
Restructuring Charge
0.00 0.00 1.20 - 0.40 16 1.00 56 13 1.70 1.50
Total Other Income / (Expense), net
-6.90 -5.60 -5.00 -8.30 -4.50 -4.70 -6.90 -4.70 -4.10 -4.80 -4.60
Interest Expense
8.90 8.80 8.40 7.70 7.70 7.90 8.00 7.60 7.20 7.80 7.20
Interest & Investment Income
1.00 2.10 3.60 -1.20 2.90 2.70 1.60 3.20 3.30 2.70 3.30
Other Income / (Expense), net
1.00 1.10 -0.20 0.60 0.30 0.50 -0.50 -0.30 -0.20 0.30 -0.70
Income Tax Expense
25 26 10 13 8.10 0.20 -2.90 9.70 -1.80 8.10 0.60
Net Income / (Loss) Attributable to Noncontrolling Interest
0.30 0.60 0.60 0.40 0.10 0.50 0.60 0.90 0.20 0.30 0.60
Basic Earnings per Share
$2.97 $3.62 $0.98 $0.59 $0.49 ($0.79) ($0.13) ($2.97) ($1.71) ($1.76) ($0.83)
Weighted Average Basic Shares Outstanding
17.34M 17.49M 17.50M 17.70M 17.56M 17.71M 17.72M 17.90M 17.82M 17.91M 17.93M
Diluted Earnings per Share
$2.93 $3.58 $0.97 $0.56 $0.48 ($0.79) ($0.13) ($2.96) ($1.71) ($1.76) ($0.83)
Weighted Average Diluted Shares Outstanding
17.59M 17.66M 17.75M 17.70M 17.77M 17.71M 17.72M 17.90M 17.82M 17.91M 17.93M
Weighted Average Basic & Diluted Shares Outstanding
17.50M 17.50M 17.51M 17.70M 17.71M 17.72M 17.73M 17.90M 17.92M 17.93M 17.95M
Cash Dividends to Common per Share
$0.33 $0.35 $0.35 - $0.35 $0.36 $0.36 - $0.36 $0.37 $0.37

Annual Cash Flow Statements for Hyster-Yale

This table details how cash moves in and out of Hyster-Yale's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
44 -112 177 -136 -19 87 -86 -6.50 20 73 41
Net Cash From Operating Activities
89 -49 165 68 77 167 -254 41 151 171 86
Net Cash From Continuing Operating Activities
89 -49 165 68 77 167 -254 41 151 193 86
Net Income / (Loss) Continuing Operations
75 42 49 34 37 39 -183 -72 128 144 -58
Consolidated Net Income / (Loss)
75 42 49 34 37 39 -183 -72 128 144 -58
Depreciation Expense
29 39 43 44 43 43 46 43 45 48 46
Amortization Expense
1.20 1.10 1.40 1.70 1.90 1.70 3.10 1.40 1.40 1.50 1.40
Non-Cash Adjustments To Reconcile Net Income
6.40 -5.40 2.90 36 34 29 43 48 61 92 65
Changes in Operating Assets and Liabilities, net
-22 -126 69 -49 -39 55 -162 19 -84 -92 32
Net Cash From Investing Activities
-31 -145 -47 -111 -42 -44 -25 -35 -35 -48 -63
Net Cash From Continuing Investing Activities
-31 -145 -47 -111 -42 -44 -25 -35 -35 -43 -58
Purchase of Property, Plant & Equipment
-47 -43 -41 -39 -50 -52 -44 -29 -35 -48 -63
Acquisitions
- -116 -1.00 -78 - 0.00 0.00 0.00 0.00 2.20 2.60
Purchase of Investments
0.00 0.00 -6.60 - - - 0.00 -8.40 -3.20 0.00 0.00
Sale of Property, Plant & Equipment
14 14 1.30 5.90 7.70 8.00 4.10 1.30 1.90 1.80 2.40
Divestitures
0.90 - - - - - 0.00 0.00 1.10 0.60 0.00
Sale and/or Maturity of Investments
- - - - 0.00 0.00 16 0.50 1.10 0.00 0.00
Net Cash From Financing Activities
-7.10 78 53 -88 -52 -41 194 -11 -101 -100 -0.80
Net Cash From Continuing Financing Activities
-7.10 78 53 -88 -52 -41 194 -11 -101 -72 8.20
Repayment of Debt
-35 -58 -192 -145 -98 -84 -70 -98 -162 -199 -173
Repurchase of Common Equity
- - - - - - - 0.00 0.00 14 4.50
Payment of Dividends
-18 -19 -20 -21 -21 -22 -22 -22 -24 -25 -27
Issuance of Debt
46 156 266 78 68 65 285 109 85 138 204
Other Net Changes in Cash
- - - - - 4.20 -1.50 -0.80 4.10 -5.20 4.00

Quarterly Cash Flow Statements for Hyster-Yale

This table details how cash moves in and out of Hyster-Yale's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-17 4.30 9.10 59 -19 -10 4.20 66 -41 -9.20 -13
Net Cash From Operating Activities
22 -2.50 70 81 -36 29 37 57 -33 17 26
Net Cash From Continuing Operating Activities
22 -2.50 70 81 -36 29 37 57 -33 17 26
Net Income / (Loss) Continuing Operations
52 64 18 11 8.70 -13 -1.70 -52 -30 -31 -14
Consolidated Net Income / (Loss)
52 64 18 11 8.70 -13 -1.70 -52 -30 -31 -14
Depreciation Expense
12 12 12 12 11 12 11 12 11 11 11
Amortization Expense
0.40 0.30 0.50 0.30 0.40 0.40 0.30 0.30 0.30 0.30 0.30
Non-Cash Adjustments To Reconcile Net Income
18 13 20 19 16 23 0.60 26 0.80 -8.50 -3.10
Changes in Operating Assets and Liabilities, net
-59 -92 20 39 -72 7.50 27 70 -15 45 32
Net Cash From Investing Activities
-7.00 -12 -12 -17 -10 -15 -14 -23 -9.30 -14 -15
Net Cash From Continuing Investing Activities
-7.00 -12 -12 -13 -10 -15 -14 -18 -9.30 -14 -15
Purchase of Property, Plant & Equipment
-7.50 -12 -10 -18 -11 -14 -15 -24 -9.80 -15 -14
Acquisitions
0.00 - - 4.40 - -2.60 - 5.20 - - -1.90
Sale of Property, Plant & Equipment
0.50 0.50 0.40 0.40 0.30 1.10 0.30 0.70 0.50 0.50 0.60
Net Cash From Financing Activities
-31 19 -51 -38 26 -26 -18 18 1.30 -11 -26
Net Cash From Continuing Financing Activities
-31 19 -51 -9.90 26 -26 -18 27 1.30 -10 -26
Repayment of Debt
-50 -54 -53 -73 -43 -41 -42 -48 -37 -43 -48
Payment of Dividends
-5.70 -7.40 -6.10 -6.10 -6.20 -7.70 -6.30 -6.50 -6.40 -6.60 -6.60
Issuance of Debt
34 81 8.40 46 79 22 31 72 45 39 29
Other Net Changes in Cash
-1.50 -0.60 1.80 - 1.40 2.30 -0.60 0.90 -0.50 -0.40 0.60

Annual Balance Sheets for Hyster-Yale

This table presents Hyster-Yale's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
1,096 1,287 1,648 1,742 1,847 1,860 545 2,026 2,079 2,029 2,021
Total Current Assets
819 810 1,131 1,132 1,156 1,130 0.00 1,459 1,490 1,433 1,347
Cash & Equivalents
155 43 220 84 65 151 - 59 79 97 123
Accounts Receivable
324 375 453 466 468 412 - 524 498 488 490
Inventories, net
305 352 412 534 560 509 - 800 816 754 634
Prepaid Expenses
35 39 46 49 63 57 - 77 98 94 100
Plant, Property, & Equipment, net
185 255 265 296 309 340 331 310 314 307 329
Total Noncurrent Assets
93 222 251 314 383 498 214 258 275 289 345
Long-Term Investments
43 46 82 76 80 80 - 59 57 56 58
Goodwill
0.00 51 59 108 107 115 57 51 53 55 56
Intangible Assets
3.60 56 56 68 60 59 51 43 39 33 32
Noncurrent Deferred & Refundable Income Taxes
33 44 17 26 31 24 - 2.60 3.00 6.70 6.80
Other Noncurrent Operating Assets
13 25 37 36 105 183 107 102 123 139 192
Total Liabilities & Shareholders' Equity
1,096 1,287 1,648 1,742 1,847 1,860 1,970 2,026 2,079 2,029 2,021
Total Liabilities
633 817 1,076 1,183 1,270 1,208 1,587 1,801 1,672 1,535 1,528
Total Current Liabilities
505 577 692 776 817 756 0.00 1,343 1,219 1,058 1,002
Short-Term Debt
34 129 75 91 82 83 - 286 253 199 242
Accounts Payable
295 259 404 437 417 428 - 586 524 448 396
Current Deferred Revenue
- - - 38 49 42 - 140 78 57 47
Current Employee Benefit Liabilities
48 44 52 56 66 46 - 64 87 106 101
Other Current Liabilities
- - - - - 182 - 245 270 241 211
Total Noncurrent Liabilities
128 240 383 406 453 738 443 725 695 719 526
Long-Term Debt
20 82 216 210 205 412 262 534 483 484 252
Asset Retirement Reserve & Litigation Obligation
18 20 34 25 31 30 - 34 51 38 43
Noncurrent Deferred & Payable Income Tax Liabilities
0.00 11 13 18 15 15 13 13 13 8.40 8.20
Other Noncurrent Operating Liabilities
69 90 109 130 188 260 169 138 149 189 224
Redeemable Noncontrolling Interest
- - - - - - 0.00 14 15 15 16
Total Equity & Noncontrolling Interests
463 470 572 560 577 651 383 211 392 479 476
Total Preferred & Common Equity
461 464 566 527 544 617 357 204 390 475 472
Total Common Equity
461 464 565 527 544 617 46 204 390 475 472
Common Stock
320 320 324 322 322 313 - 298 328 351 355
Retained Earnings
337 360 389 407 427 443 249 153 256 375 289
Treasury Stock
-43 -37 -32 -24 -16 -6.00 - - 0.00 -14 -14
Accumulated Other Comprehensive Income / (Loss)
-154 -179 -116 -178 -189 -133 -202 -246 -194 -237 -158
Noncontrolling Interest
1.90 6.60 6.90 32 33 34 26 6.50 2.10 4.10 4.30

Quarterly Balance Sheets for Hyster-Yale

This table presents Hyster-Yale's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
2,110 2,053 2,118 2,116 2,172 2,055 2,075 2,061 1,958 1,928 1,932
Total Current Assets
1,552 1,501 1,526 1,529 1,559 1,455 1,457 1,444 1,305 1,277 1,280
Cash & Equivalents
66 78 62 67 76 77 67 71 82 73 59
Accounts Receivable
582 512 521 579 543 506 512 521 471 485 469
Inventories, net
820 815 842 791 855 773 777 740 644 628 665
Prepaid Expenses
84 95 101 93 86 99 101 112 108 92 88
Plant, Property, & Equipment, net
300 299 312 311 317 313 316 321 328 327 328
Total Noncurrent Assets
258 254 281 276 296 287 302 296 326 325 324
Long-Term Investments
52 54 52 53 60 52 56 57 52 53 58
Goodwill
52 51 52 52 58 51 55 56 55 56 55
Intangible Assets
41 40 37 36 36 33 34 33 31 30 30
Noncurrent Deferred & Refundable Income Taxes
2.90 2.60 3.00 2.70 2.80 6.90 7.90 8.00 7.30 3.50 4.10
Other Noncurrent Operating Assets
109 106 136 133 139 144 149 143 181 182 177
Total Liabilities & Shareholders' Equity
2,110 2,053 2,118 2,116 2,172 2,055 2,075 2,061 1,958 1,928 1,932
Total Liabilities
1,804 1,733 1,689 1,634 1,623 1,526 1,512 1,505 1,507 1,518 1,542
Total Current Liabilities
1,371 1,299 1,221 1,172 1,149 1,054 1,042 1,037 993 1,000 1,036
Short-Term Debt
290 267 235 253 221 241 228 216 254 241 231
Accounts Payable
577 540 566 507 528 464 465 472 400 414 465
Current Deferred Revenue
120 99 71 66 64 52 48 44 50 49 47
Current Employee Benefit Liabilities
59 70 52 67 83 65 78 87 65 69 70
Other Current Liabilities
309 313 290 272 247 221 214 214 215 217 215
Total Noncurrent Liabilities
432 433 468 462 475 472 470 468 514 519 507
Long-Term Debt
252 243 240 249 247 243 245 252 251 259 254
Asset Retirement Reserve & Litigation Obligation
35 42 46 36 38 41 37 38 44 44 45
Noncurrent Deferred & Payable Income Tax Liabilities
12 12 12 12 12 9.80 10 9.20 8.10 7.70 7.70
Other Noncurrent Operating Liabilities
127 131 166 161 172 179 177 168 211 208 200
Redeemable Noncontrolling Interest
14 14 15 14 0.00 15 15 15 17 16 17
Total Equity & Noncontrolling Interests
292 306 414 468 534 514 549 540 434 394 373
Total Preferred & Common Equity
291 304 412 466 530 510 545 536 430 390 371
Total Common Equity
291 304 412 466 530 510 545 536 430 390 371
Common Stock
310 313 337 345 350 353 355 357 348 349 347
Retained Earnings
207 237 302 359 370 377 357 348 252 214 193
Treasury Stock
-0.10 0.00 -9.10 -9.10 -8.70 -17 -16 -15 -3.90 -3.00 -2.30
Accumulated Other Comprehensive Income / (Loss)
-225 -245 -218 -230 -181 -204 -151 -153 -166 -170 -167
Noncontrolling Interest
1.80 1.80 2.30 2.20 4.10 4.30 4.20 4.30 4.30 3.90 2.40

Annual Metrics And Ratios for Hyster-Yale

This table displays calculated financial ratios and metrics derived from Hyster-Yale's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
16,323,816.00 16,390,754.00 16,462,320.00 16,560,722.00 16,666,917.00 16,805,437.00 16,826,900.00 - - - 17,733,794.00
DEI Adjusted Shares Outstanding
16,323,816.00 16,390,754.00 16,462,320.00 16,560,722.00 16,666,917.00 16,805,437.00 16,826,900.00 - - - 17,733,794.00
DEI Earnings Per Adjusted Shares Outstanding
4.58 2.61 2.95 2.10 2.15 2.21 -10.28 - - - -3.39
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
74 36 39 36 41 46 -107 -27 148 161 -15
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -2.66% 13.10% 17.52% -1.59%
Earnings before Interest and Taxes (EBIT)
103 38 80 43 58 49 -151 -45 209 247 -22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
133 78 125 88 104 94 -102 -0.20 255 296 25
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
93 -238 70 -104 23 51 243 -345 57 143 -35
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
318 593 561 702 719 714 364 681 772 790 810
Increase / (Decrease) in Invested Capital
-19 275 -31 141 18 -5.90 -350 318 91 19 20
Book Value per Share
$28.22 $28.28 $34.34 $31.83 $32.66 $36.71 $2.75 $12.07 $22.69 $27.14 $26.62
Tangible Book Value per Share
$28.00 $21.76 $27.34 $21.21 $22.65 $26.40 ($3.62) $6.52 $17.30 $22.13 $21.65
Total Capital
516 682 863 861 864 1,146 645 1,045 1,142 935 987
Total Debt
53 211 291 302 287 495 262 820 735 441 494
Total Long-Term Debt
20 82 216 210 205 412 262 534 483 242 252
Net Debt
-145 122 -11 142 142 264 262 702 600 289 313
Capital Expenditures (CapEx)
32 29 40 33 42 44 40 28 34 46 60
Debt-free, Cash-free Net Working Capital (DFCFNWC)
192 319 293 363 357 306 0.00 343 445 478 464
Debt-free Net Working Capital (DFNWC)
347 363 514 447 421 457 0.00 402 524 574 588
Net Working Capital (NWC)
314 234 439 355 339 374 0.00 116 272 375 345
Net Nonoperating Expense (NNE)
-0.72 -5.96 -10 2.06 4.58 7.02 77 44 20 17 43
Net Nonoperating Obligations (NNO)
-145 122 -11 142 142 62 -19 456 365 296 318
Total Depreciation and Amortization (D&A)
30 40 44 46 45 45 49 45 47 49 47
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.58 $2.61 $2.95 $2.10 $2.15 $2.21 ($10.29) ($4.38) $7.35 $8.16 ($3.40)
Adjusted Weighted Average Basic Shares Outstanding
16.33M 16.40M 16.47M 16.57M 16.67M 16.81M 16.84M 17.16M 17.49M 17.70M 17.90M
Adjusted Diluted Earnings per Share
$4.57 $2.61 $2.94 $2.09 $2.14 $2.21 ($10.29) ($4.38) $7.24 $8.04 ($3.40)
Adjusted Weighted Average Diluted Shares Outstanding
16.33M 16.40M 16.47M 16.57M 16.67M 16.81M 16.84M 17.16M 17.49M 17.70M 17.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
16.33M 16.40M 16.47M 16.57M 16.67M 16.81M 16.84M 17.16M 17.49M 17.70M 17.90M
Normalized Net Operating Profit after Tax (NOPAT)
74 23 39 36 41 46 -61 -27 148 166 40
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Quarterly Metrics And Ratios for Hyster-Yale

This table displays calculated financial ratios and metrics derived from Hyster-Yale's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - 17,707,665.00 17,720,627.00 17,733,794.00 17,900,088.00 17,915,902.00 17,930,387.00
DEI Adjusted Shares Outstanding
- - - - - 17,707,665.00 17,720,627.00 17,733,794.00 17,900,088.00 17,915,902.00 17,930,387.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - -0.79 -0.13 -2.96 -1.70 -1.76 -0.83
Growth Metrics
- - - - - - - - - - -
Revenue Growth
5.72% 7.11% 1.49% 3.92% -13.83% -18.11% -3.64% - -12.65% -15.02% -15.49%
EBITDA Growth
73.66% 61.36% -36.39% -25.62% -65.94% -96.16% -70.29% - -150.30% -264.29% -85.82%
EBIT Growth
91.42% 72.37% -44.52% -32.58% -74.53% -108.27% -94.53% - -230.56% -126.25% -644.44%
NOPAT Growth
74.89% 51.14% -48.30% -52.02% -80.46% -108.77% -92.32% - -277.69% -116.47% -495.65%
Net Income Growth
90.44% 64.69% -51.10% -58.37% -83.20% -120.97% -109.55% - -448.28% -133.58% -741.18%
EPS Growth
89.03% 61.99% -52.91% -60.56% -83.62% -122.07% -113.40% - -456.25% -122.78% -538.46%
Operating Cash Flow Growth
148.89% -106.98% 16.25% 76.97% -262.50% 1,256.00% -47.08% - 9.62% -42.21% -29.11%
Free Cash Flow Firm Growth
-204.97% 91.92% -42.57% 93.24% 88.29% -1.28% 93.91% - 149.84% 303.69% 1,409.91%
Invested Capital Growth
0.00% 16.68% 25.42% 2.40% 12.26% 5.91% 1.27% - -7.02% -14.07% -14.82%
Revenue Q/Q Growth
2.85% 10.56% -13.01% 5.06% -14.72% 5.07% 2.35% - -13.86% 2.23% 1.78%
EBITDA Q/Q Growth
60.17% 12.90% -58.78% -0.22% -26.67% -87.27% 219.05% - 34.90% 58.43% 127.54%
EBIT Q/Q Growth
73.77% 14.03% -65.98% 0.00% -34.35% -137.04% 122.50% - 24.80% 35.82% 45.86%
NOPAT Q/Q Growth
88.07% 20.25% -69.11% -31.32% -23.40% -153.94% 127.06% - 24.73% 34.29% 50.54%
Net Income Q/Q Growth
101.56% 23.36% -72.14% -39.89% -18.69% -254.02% 87.31% - 41.28% -3.30% 54.31%
EPS Q/Q Growth
106.34% 22.18% -72.91% -42.27% -14.29% -264.58% 83.54% - 42.23% -2.92% 52.84%
Operating Cash Flow Q/Q Growth
-50.88% -111.16% 2,904.00% 15.12% -145.11% 179.40% 28.37% - -158.23% 150.76% 57.49%
Free Cash Flow Firm Q/Q Growth
-1,119.81% 92.34% -180.36% 97.42% -2,014.11% 33.71% 83.13% - 193.83% 170.88% 8.47%
Invested Capital Q/Q Growth
3.21% 9.41% 1.89% -11.01% 13.16% 3.22% -2.57% - 2.62% -4.61% -3.42%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
22.31% 22.20% 18.98% 19.45% 19.52% 17.58% 15.92% - 15.69% 15.70% 15.00%
EBITDA Margin
9.17% 9.37% 4.44% 4.22% 3.62% 0.44% 1.37% - -2.09% -0.85% 0.23%
Operating Margin
7.93% 8.18% 3.26% 3.03% 2.34% -0.89% 0.23% - -3.52% -2.26% -1.10%
EBIT Margin
8.03% 8.28% 3.24% 3.08% 2.37% -0.84% 0.18% - -3.55% -2.23% -1.18%
Profit (Net Income) Margin
4.90% 5.47% 1.75% 1.00% 0.96% -1.40% -0.17% - -3.81% -3.85% -1.73%
Tax Burden Percent
67.36% 71.00% 63.35% 44.58% 51.79% 101.52% 36.96% - 94.39% 134.91% 104.38%
Interest Burden Percent
90.68% 93.07% 85.41% 72.95% 77.78% 165.00% -255.56% - 113.83% 128.18% 139.80%
Effective Tax Rate
32.64% 29.00% 36.65% 55.42% 48.21% 0.00% 0.00% - 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
56.00% 30.53% 11.03% 7.44% 5.96% -2.74% 0.72% - -10.44% -6.48% -3.10%
ROIC Less NNEP Spread (ROIC-NNEP)
53.47% 29.58% 10.18% 6.32% 5.33% -4.73% -0.23% - -13.31% -11.44% -5.31%
Return on Net Nonoperating Assets (RNNOA)
45.76% 31.16% 8.84% 4.64% 4.07% -3.39% -0.15% - -10.12% -8.73% -4.04%
Return on Equity (ROE)
101.77% 61.69% 19.87% 12.08% 10.03% -6.13% 0.57% - -20.56% -15.21% -7.15%
Cash Return on Invested Capital (CROIC)
-156.85% 8.72% -0.54% 18.27% 2.16% -2.02% -0.27% - 1.49% 8.50% 8.21%
Operating Return on Assets (OROA)
15.82% 16.66% 6.54% 6.46% 4.73% -1.58% 0.34% - -6.46% -3.90% -1.99%
Return on Assets (ROA)
9.66% 11.01% 3.54% 2.10% 1.91% -2.64% -0.32% - -6.94% -6.75% -2.91%
Return on Common Equity (ROCE)
97.69% 59.18% 19.40% 11.60% 9.65% -5.92% 0.56% - -19.72% -14.61% -6.86%
Return on Equity Simple (ROE_SIMPLE)
37.05% 38.18% 30.04% 0.00% 19.82% 0.00% 0.00% - 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
56 68 21 14 11 -5.95 1.61 -26 -20 -13 -6.37
NOPAT Margin
5.34% 5.81% 2.06% 1.35% 1.21% -0.62% 0.16% - -2.46% -1.58% -0.77%
Net Nonoperating Expense Percent (NNEP)
2.53% 0.96% 0.85% 1.12% 0.64% 1.99% 0.95% - 2.87% 4.96% 2.20%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.57% 1.10% -0.58% 0.16% -2.68% -2.09% -1.44% -0.74%
Cost of Revenue to Revenue
77.69% 77.80% 81.02% 80.55% 80.48% 82.42% 84.08% - 84.31% 84.30% 85.00%
SG&A Expenses to Revenue
14.38% 14.01% 15.73% 14.30% 17.16% 16.83% 15.59% - 19.01% 17.75% 15.92%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Operating Expenses to Revenue
14.38% 14.01% 15.73% 14.94% 17.10% 18.47% 15.79% - 20.59% 17.96% 16.10%
Earnings before Interest and Taxes (EBIT)
85 97 33 33 22 -8.00 1.80 -38 -28 -18 -9.80
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
97 109 45 45 33 4.20 13 -26 -17 -6.90 1.90
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.66 2.62 2.11 1.88 1.44 1.29 1.22 - 1.35 1.61 1.52
Price to Tangible Book Value (P/TBV)
3.40 3.23 2.56 2.30 1.73 1.55 1.46 - 1.69 2.06 1.97
Price to Revenue (P/Rev)
0.26 0.29 0.26 0.21 0.18 0.18 0.17 - 0.16 0.18 0.17
Price to Earnings (P/E)
7.28 6.94 7.10 6.27 7.40 31.73 241.92 - 0.00 0.00 0.00
Dividend Yield
2.04% 1.90% 2.12% 2.70% 3.37% 3.54% 3.85% - 4.43% 4.12% 4.61%
Earnings Yield
13.74% 14.41% 14.09% 15.96% 13.52% 3.15% 0.41% - 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.85 1.86 1.64 1.52 1.24 1.16 1.13 - 1.17 1.29 1.24
Enterprise Value to Revenue (EV/Rev)
0.35 0.38 0.34 0.28 0.27 0.27 0.26 - 0.27 0.29 0.28
Enterprise Value to EBITDA (EV/EBITDA)
4.98 4.79 4.66 4.05 4.77 8.43 10.59 - 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
5.92 5.59 5.52 4.85 6.03 13.52 20.97 - 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
8.58 8.30 8.27 7.44 9.57 32.13 114.28 - 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
8.99 12.87 10.72 7.03 9.91 7.49 9.18 - 10.88 13.21 14.29
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 22.95 0.00 8.41 60.66 0.00 0.00 - 76.01 14.01 13.92
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.11 1.04 0.88 0.89 0.91 0.84 0.84 - 1.12 1.22 1.24
Long-Term Debt to Equity
0.56 0.52 0.46 0.49 0.46 0.44 0.45 - 0.56 0.63 0.65
Financial Leverage
0.86 1.05 0.87 0.73 0.76 0.72 0.64 - 0.76 0.76 0.76
Leverage Ratio
4.93 5.36 4.94 4.56 4.35 4.01 3.89 - 4.09 4.11 4.22
Compound Leverage Factor
4.47 4.99 4.22 3.33 3.39 6.61 -9.93 - 4.66 5.27 5.90
Debt to Total Capital
52.52% 51.01% 46.73% 47.14% 47.76% 45.65% 45.72% - 52.84% 54.95% 55.41%
Short-Term Debt to Total Capital
26.00% 25.75% 22.05% 21.27% 23.82% 22.00% 21.07% - 26.58% 26.46% 26.39%
Long-Term Debt to Total Capital
26.51% 25.25% 24.68% 25.88% 23.94% 23.65% 24.65% - 26.26% 28.48% 29.03%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.90% 1.67% 0.41% 2.03% 1.91% 1.80% 1.90% - 2.18% 2.20% 2.17%
Common Equity to Total Capital
45.58% 47.33% 52.86% 50.82% 50.33% 52.55% 52.38% - 44.98% 42.86% 42.41%
Debt to EBITDA
1.60 1.49 1.50 1.49 2.08 3.72 4.89 - -20.62 -14.04 -10.29
Net Debt to EBITDA
1.22 1.13 1.07 0.97 1.53 2.75 3.56 - -15.17 -10.51 -7.83
Long-Term Debt to EBITDA
0.81 0.74 0.79 0.82 1.04 1.93 2.64 - -10.25 -7.28 -5.39
Debt to NOPAT
2.76 2.57 2.67 2.73 4.17 14.16 52.79 - -10.11 -8.79 -7.47
Net Debt to NOPAT
2.10 1.96 1.90 1.79 3.06 10.49 38.38 - -7.44 -6.58 -5.68
Long-Term Debt to NOPAT
1.39 1.27 1.41 1.50 2.09 7.34 28.46 - -5.02 -4.55 -3.91
Altman Z-Score
2.87 3.05 2.89 3.01 2.84 2.65 2.64 - 2.42 2.37 2.23
Noncontrolling Interest Sharing Ratio
4.01% 4.07% 2.38% 3.98% 3.82% 3.36% 2.16% - 4.10% 3.98% 4.06%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.25 1.31 1.36 1.35 1.38 1.40 1.39 - 1.31 1.28 1.24
Quick Ratio
0.48 0.55 0.54 0.55 0.55 0.56 0.57 - 0.56 0.56 0.51
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-740 -57 -159 -4.10 -87 -57 -9.69 -46 43 117 127
Operating Cash Flow to CapEx
320.00% -21.37% 715.31% 461.14% -353.40% 227.56% 261.27% - -353.76% 117.61% 199.24%
Free Cash Flow to Firm to Interest Expense
-83.17 -6.45 -18.93 -0.53 -11.26 -7.27 -1.21 - 6.00 15.00 17.63
Operating Cash Flow to Interest Expense
2.52 -0.28 8.35 10.48 -4.73 3.66 4.64 - -4.57 2.14 3.65
Operating Cash Flow Less CapEx to Interest Expense
1.73 -1.61 7.18 8.21 -6.06 2.05 2.86 - -5.86 0.32 1.82
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.97 2.01 2.02 2.10 1.99 1.89 1.85 - 1.82 1.75 1.68
Accounts Receivable Turnover
8.02 7.33 8.09 8.74 8.11 7.24 7.36 - 7.48 7.04 6.79
Inventory Turnover
3.95 4.15 4.03 4.35 4.12 4.09 4.02 - 4.34 4.23 4.06
Fixed Asset Turnover
13.39 13.92 13.87 13.88 13.32 12.59 12.28 - 11.41 10.92 10.36
Accounts Payable Turnover
5.88 6.17 6.31 7.03 6.46 6.59 6.41 - 7.12 6.76 6.09
Days Sales Outstanding (DSO)
45.50 49.81 45.09 41.76 45.01 50.39 49.57 - 48.81 51.83 53.78
Days Inventory Outstanding (DIO)
92.32 87.89 90.47 83.96 88.63 89.27 90.88 - 84.09 86.25 89.94
Days Payable Outstanding (DPO)
62.05 59.13 57.84 51.94 56.54 55.36 56.95 - 51.29 54.02 59.96
Cash Conversion Cycle (CCC)
75.76 78.58 77.72 73.78 77.11 84.30 83.50 - 81.62 84.05 83.76
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
797 872 888 790 894 923 900 810 832 793 766
Invested Capital Turnover
10.48 5.25 5.35 5.52 4.92 4.40 4.38 - 4.23 4.09 4.03
Increase / (Decrease) in Invested Capital
797 125 180 19 98 52 11 20 -63 -130 -133
Enterprise Value (EV)
1,475 1,619 1,453 1,199 1,109 1,074 1,013 - 974 1,022 952
Market Capitalization
1,098 1,220 1,116 892 735 704 653 - 582 628 564
Book Value per Share
$23.77 $26.62 $30.28 $27.14 $28.82 $30.76 $30.25 $26.62 $24.03 $21.77 $20.69
Tangible Book Value per Share
$18.62 $21.62 $24.88 $22.13 $24.06 $25.72 $25.25 $21.65 $19.25 $16.98 $15.95
Total Capital
904 984 1,003 935 1,013 1,037 1,023 987 956 910 875
Total Debt
475 502 469 441 484 473 468 494 505 500 485
Total Long-Term Debt
240 249 247 242 243 245 252 252 251 259 254
Net Debt
361 383 333 289 355 351 340 313 372 374 369
Capital Expenditures (CapEx)
7.00 12 9.80 18 10 13 14 23 9.30 14 13
Debt-free, Cash-free Net Working Capital (DFCFNWC)
478 545 556 478 565 576 551 464 485 445 417
Debt-free Net Working Capital (DFNWC)
540 611 632 574 642 643 622 588 566 518 476
Net Working Capital (NWC)
305 358 411 375 401 415 407 345 312 277 245
Net Nonoperating Expense (NNE)
4.65 3.98 3.17 3.70 2.33 7.45 3.31 26 11 18 7.93
Net Nonoperating Obligations (NNO)
367 390 354 296 365 360 344 318 381 383 376
Total Depreciation and Amortization (D&A)
12 13 12 12 11 12 12 12 12 11 12
Debt-free, Cash-free Net Working Capital to Revenue
11.45% 12.81% 13.03% 11.09% 13.58% 14.57% 14.09% - 13.26% 12.69% 12.42%
Debt-free Net Working Capital to Revenue
12.94% 14.37% 14.80% 13.33% 15.43% 16.26% 15.90% - 15.50% 14.76% 14.16%
Net Working Capital to Revenue
7.31% 8.41% 9.62% 8.71% 9.63% 10.49% 10.39% - 8.54% 7.90% 7.29%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.97 $3.62 $0.98 $0.59 $0.49 ($0.79) ($0.13) ($2.97) ($1.71) ($1.76) ($0.83)
Adjusted Weighted Average Basic Shares Outstanding
17.34M 17.49M 17.50M 17.70M 17.56M 17.71M 17.72M 17.90M 17.82M 17.91M 17.93M
Adjusted Diluted Earnings per Share
$2.93 $3.58 $0.97 $0.56 $0.48 ($0.79) ($0.13) ($2.96) ($1.71) ($1.76) ($0.83)
Adjusted Weighted Average Diluted Shares Outstanding
17.59M 17.66M 17.75M 17.70M 17.77M 17.71M 17.72M 17.90M 17.82M 17.91M 17.93M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
17.50M 17.50M 17.51M 17.70M 17.71M 17.72M 17.73M 17.90M 17.92M 17.93M 17.95M
Normalized Net Operating Profit after Tax (NOPAT)
56 68 21 23 11 5.04 3.01 13 -11 -12 -5.32
Normalized NOPAT Margin
5.34% 5.81% 2.06% 2.12% 1.18% 0.53% 0.31% - -1.36% -1.44% -0.64%
Pre Tax Income Margin
7.28% 7.70% 2.77% 2.25% 1.85% -1.38% -0.47% - -4.04% -2.85% -1.66%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
9.53 10.99 3.92 4.27 2.81 -1.01 0.23 - -3.92 -2.32 -1.36
NOPAT to Interest Expense
6.34 7.71 2.50 1.87 1.43 -0.75 0.20 - -2.72 -1.65 -0.88
EBIT Less CapEx to Interest Expense
8.74 9.66 2.75 2.00 1.47 -2.62 -1.55 - -5.21 -4.14 -3.19
NOPAT Less CapEx to Interest Expense
5.56 6.38 1.33 -0.40 0.09 -2.36 -1.57 - -4.01 -3.47 -2.72
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
15.52% 13.67% 15.58% 17.55% 25.52% 109.66% 611.63% - -27.73% -23.59% -21.49%
Augmented Payout Ratio
15.52% 13.67% 15.58% 7.84% 7.12% 31.09% 179.07% - -19.18% -16.45% -14.98%

Financials Breakdown Chart

Key Financial Trends

Hyster-Yale’s financial results show a company still working through a significant downturn in demand and profitability. Revenue and earnings remain well below 2023 and 2024 levels, although the second quarter of 2026 showed sequential improvement in operating losses and operating cash flow.

  • Operating cash flow turned positive in Q2 2026. Cash from operations was $16.7 million, a meaningful improvement from the $32.9 million outflow in Q1 2026. After $14.7 million of capital expenditures, the company generated modest positive cash flow before other investing items.
  • Inventory has been reduced substantially. Net inventory declined to $627.5 million in Q2 2026 from $776.6 million a year earlier and $855.3 million in Q3 2024. This reduction can lessen working-capital requirements and reduce the risk of excess inventory if demand remains weak.
  • The operating loss improved sequentially. Q2 2026 operating loss was $18.4 million, compared with a $28.0 million loss in Q1. The improvement came despite only modest revenue growth, as selling, general and administrative expense fell to $144.3 million from $151.2 million and restructuring expense declined to $1.7 million from $12.5 million.
  • Debt repayment continues. Hyster-Yale repaid $42.6 million of debt in Q2 2026, partially offset by $39.2 million of new borrowings. Total debt was approximately $500.0 million at quarter-end, which remains elevated but reflects ongoing efforts to manage the debt balance.
  • Liquidity has improved from the 2024 period. Cash and equivalents of $72.6 million in Q2 2026 exceeded the $66.9 million reported in Q2 2025 and the $66.5 million reported in Q2 2024. Current assets of $1.28 billion also exceeded current liabilities of $999.6 million, producing a current ratio of approximately 1.3.
  • Revenue remains volatile and below historical levels. Q2 2026 revenue increased modestly to $812.9 million from $795.2 million in Q1, but was down from $956.6 million in Q2 2025, $1.17 billion in Q2 2024 and $1.09 billion in Q2 2023. The multi-year decline suggests that the improvement in Q2 may not yet represent a durable recovery.
  • Cash generation has been inconsistent. Operating cash flow was positive in Q2 2026 and Q3 2025, but negative in Q1 2026 and Q2 2025. Earlier periods also benefited from large working-capital movements and non-cash adjustments, so investors should focus on whether positive operating cash flow persists as earnings recover.
  • Hyster-Yale remains unprofitable. The company reported a $31.3 million consolidated net loss and a $31.6 million loss attributable to common shareholders in Q2 2026. Diluted loss per share was $1.76, compared with a $0.79 loss in Q2 2025 and a $3.58 profit in Q2 2024.
  • Profit margins have deteriorated sharply. Q2 2026 gross margin was approximately 15.7%, down from 17.6% in Q2 2025 and 22.2% in Q2 2024. The operating margin was approximately negative 2.3%, compared with positive operating margins in 2023 and 2024, indicating that lower sales and cost pressure continue to weigh on profitability.
  • Shareholders’ equity has declined while leverage remains material. Total equity and noncontrolling interests fell to $393.9 million in Q2 2026 from $548.9 million in Q2 2024, largely reflecting accumulated losses and other comprehensive losses. With roughly $427 million of net debt after subtracting cash, the company has limited balance-sheet flexibility if losses continue.
  • The dividend is being maintained despite recurring losses. Hyster-Yale paid $6.6 million in dividends during Q2 2026 and declared a dividend of $0.365 per share. Continuing distributions while reporting losses and using debt financing may constrain cash available for debt reduction and investment, although the quarterly dividend has remained relatively stable.

Overall, Hyster-Yale’s Q2 2026 results offer some early signs of stabilization in inventory, operating expenses, and operating cash flow. However, the broader trend remains challenging: revenue is well below prior-year levels, margins are compressed, earnings are negative, and leverage is significant. A sustained recovery in demand and a return to positive operating income will likely be necessary before the company’s financial position materially strengthens.

11/17/26 07:05 PM ETAI Generated. May Contain Errors.

Hyster-Yale Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Hyster-Yale's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Hyster-Yale's net income appears to be on a downward trend, with a most recent value of -$58 million in 2025, compared with $75.10 million in 2015. The previous period was $144.20 million in 2024. View Hyster-Yale's forecast to see where analysts expect Hyster-Yale to go next.

Hyster-Yale's total operating income in 2025 was -$22.10 million, based on the following breakdown:
  • Total Gross Profit: $632.80 million
  • Total Operating Expenses: $696.40 million

Over the last 10 years, Hyster-Yale's total revenue changed from $2.58 billion in 2015 to $3.77 billion in 2025, a change of 46.2%.

In the past 13 quarters, Hyster-Yale's cash and equivalents has ranged from $58.50 million in Q3 2026 to $81.80 million in Q1 2026, and is currently $58.50 million as of their latest financial filing in Q3 2026.

Hyster-Yale had total debt of $494.30 million at the end of 2025, a 12.2% increase from 2024, and a 830.9% increase since 2015.

Over the last 10 years, Hyster-Yale's book value per share changed from 28.22 in 2015 to 26.62 in 2025, a change of -5.7%.



Financial statements for NYSE:HY last updated on 11/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners